These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
381 related items for PubMed ID: 28815847
1. Mastitis treatment-Reduction in antibiotic usage in dairy cows. Krömker V, Leimbach S. Reprod Domest Anim; 2017 Aug; 52 Suppl 3():21-29. PubMed ID: 28815847 [Abstract] [Full Text] [Related]
2. Antimicrobial resistance of mastitis pathogens. Oliver SP, Murinda SE. Vet Clin North Am Food Anim Pract; 2012 Jul; 28(2):165-85. PubMed ID: 22664201 [Abstract] [Full Text] [Related]
3. Monitoring udder health on routinely collected census data: Evaluating the short- to mid-term consequences of implementing selective dry cow treatment. Santman-Berends IMGA, van den Heuvel KWH, Lam TJGM, Scherpenzeel CGM, van Schaik G. J Dairy Sci; 2021 Feb; 104(2):2280-2289. PubMed ID: 33358166 [Abstract] [Full Text] [Related]
4. Herd-level relationship between antimicrobial use and presence or absence of antimicrobial resistance in gram-negative bovine mastitis pathogens on Canadian dairy farms. Saini V, McClure JT, Scholl DT, DeVries TJ, Barkema HW. J Dairy Sci; 2013 Aug; 96(8):4965-76. PubMed ID: 23769367 [Abstract] [Full Text] [Related]
5. Veterinarians' attitudes toward antimicrobial use and selective dry cow treatment in the Netherlands. Scherpenzeel CGM, Santman-Berends IMGA, Lam TJGM. J Dairy Sci; 2018 Jul; 101(7):6336-6345. PubMed ID: 29605325 [Abstract] [Full Text] [Related]
6. Effect of different scenarios for selective dry-cow therapy on udder health, antimicrobial usage, and economics. Scherpenzeel CGM, den Uijl IEM, van Schaik G, Riekerink RGMO, Hogeveen H, Lam TJGM. J Dairy Sci; 2016 May; 99(5):3753-3764. PubMed ID: 26947289 [Abstract] [Full Text] [Related]
7. Antimicrobial resistance in beef and dairy cattle production. Call DR, Davis MA, Sawant AA. Anim Health Res Rev; 2008 Dec; 9(2):159-67. PubMed ID: 18983724 [Abstract] [Full Text] [Related]
8. Impact of antibiotic use in adult dairy cows on antimicrobial resistance of veterinary and human pathogens: a comprehensive review. Oliver SP, Murinda SE, Jayarao BM. Foodborne Pathog Dis; 2011 Mar; 8(3):337-55. PubMed ID: 21133795 [Abstract] [Full Text] [Related]
9. Evaluation of udder health parameters and risk factors for clinical mastitis in Dutch dairy herds in the context of a restricted antimicrobial usage policy. Santman-Berends IMGA, Swinkels JM, Lam TJGM, Keurentjes J, van Schaik G. J Dairy Sci; 2016 Apr; 99(4):2930-2939. PubMed ID: 26874413 [Abstract] [Full Text] [Related]
10. Antimicrobial usage and risk of retreatment for mild to moderate clinical mastitis cases on dairy farms following on-farm bacterial culture and selective therapy. McDougall S, Niethammer J, Graham EM. N Z Vet J; 2018 Mar; 66(2):98-107. PubMed ID: 29241025 [Abstract] [Full Text] [Related]
19. Understanding barriers to reducing antimicrobials on Australian dairy farms: A qualitative analysis. Langhorne C, Wood BJ, Wood C, Henning J, McGowan M, Schull D, Ranjbar S, Gibson JS. Aust Vet J; 2024 Jun; 102(6):285-292. PubMed ID: 38342502 [Abstract] [Full Text] [Related]
20. The informative value of an overview on antibiotic consumption, treatment efficacy and cost of clinical mastitis at farm level. Doehring C, Sundrum A. Prev Vet Med; 2019 Apr 01; 165():63-70. PubMed ID: 30851929 [Abstract] [Full Text] [Related] Page: [Next] [New Search]